Generating transfectants explicitly expressing just a single splice variant of CEACAM1 in the human melanoma cell line, Ma-Mel-86a (Figures S1A,B in Supplementary Material) we recently identified, that CEACAM1 expression impacts melanoma progression and antitumor immunity in a variant-specific mode of action (31). The gene discussed is CEACAM1; the disease is melanoma.